XOLREMDI 100 mg/1
mavorixafor · CAPSULE, GELATIN COATED · X4 Pharmaceuticals, Inc.
Mavorixafor (Xolremdi) is an oral capsule medication that works by blocking a specific chemokine receptor involved in immune cell movement, used to treat certain rare immunodeficiency disorders. This prescription medication comes in 100 mg capsules and is taken by mouth as directed by your doctor.
Key Facts
- Brand Name
- XOLREMDI
- Generic Name
- mavorixafor
- NDC Code (Product)
83296-100- Manufacturer
- X4 Pharmaceuticals, Inc.
- Strength
- 100 mg/1
- Dosage Form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218709
- Drug Class
- CXC Chemokine Receptor 4 Antagonist [EPC]
- Marketing Start
- 05/21/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is XOLREMDI used for?
Mavorixafor (Xolremdi) is an oral capsule medication that works by blocking a specific chemokine receptor involved in immune cell movement, used to treat certain rare immunodeficiency disorders. This prescription medication comes in 100 mg capsules and is taken by mouth as directed by your doctor.
Is XOLREMDI a controlled substance?
XOLREMDI is not classified as a controlled substance by the DEA.
What is the generic name for XOLREMDI?
The generic name for XOLREMDI is mavorixafor. There are no other listed brand versions of mavorixafor.
What is the NDC code for XOLREMDI 100 mg/1?
The NDC (National Drug Code) for XOLREMDI 100 mg/1 is 83296-100, listed by X4 Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)